{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:39:38Z","timestamp":1788511178032,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI138932"],"award-info":[{"award-number":["T32 AI138932"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI142785"],"award-info":[{"award-number":["U19 AI142785"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.celrep.2023.112370","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T05:12:38Z","timestamp":1680844358000},"page":"112370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes"],"prefix":"10.1016","volume":"42","author":[{"given":"Elaine C.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlo","family":"Gilchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Zost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp A.","family":"Ilinykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Binshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bonissone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrahaas R.","family":"Kona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Trivette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph X.","family":"Reidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gainza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazmean K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher N.","family":"Selverian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Doranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Castellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bukreyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Carnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.112370_bib1","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1901594","article-title":"Ebola","volume":"382","author":"Feldmann","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.112370_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chom.2018.12.005","article-title":"A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates","volume":"25","author":"Bornholdt","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112370_bib3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112370_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","article-title":"Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad Ebolavirus neutralization","volume":"52","author":"Gilchuk","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112370_bib5","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/infdis\/jiy285","article-title":"Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates","volume":"218","author":"Pascal","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112370_bib6","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1056\/NEJMe1915350","article-title":"Monoclonal antibody therapy for Ebola virus disease","volume":"381","author":"Levine","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.112370_bib7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41591-019-0602-4","article-title":"Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV","volume":"25","author":"Ehrhardt","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112370_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.celrep.2019.03.020","article-title":"Therapeutic monoclonal antibodies for Ebola virus infection derived from vaccinated humans","volume":"27","author":"Rijal","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112370_bib9","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","article-title":"Longitudinal analysis of the human B cell response to Ebola virus infection","volume":"177","author":"Davis","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112370_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing sntibody responses in human survivors of natural Ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112370_bib11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112370_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.aad6117","article-title":"Structural and molecular basis for Ebola virus neutralization by protective human antibodies","volume":"351","author":"Misasi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112370_bib13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cell.2017.04.037","article-title":"Antibodies from a human survivor define sites of vulnerability for broad protection against Ebolaviruses","volume":"169","author":"Wec","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112370_bib14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.chom.2020.01.007","article-title":"Structural basis for a convergent immune response against Ebola virus","volume":"27","author":"Cohen-Dvashi","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112370_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112370_bib16","doi-asserted-by":"crossref","first-page":"e01439-18","DOI":"10.1128\/JVI.01439-18","article-title":"Early human B cell response to ebola virus in four U.S. survivors of infection","volume":"93","author":"Williamson","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112370_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108984","article-title":"Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies","volume":"35","author":"Murin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112370_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature13764","article-title":"Rapid development of broadly influenza neutralizing antibodies through redundant mutations","volume":"516","author":"Pappas","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112370_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41564-021-00972-2","article-title":"Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail","volume":"6","author":"Dong","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2023.112370_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1126\/science.abd2321","article-title":"Structural basis of a shared antibody response to SARS-CoV-2","volume":"369","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112370_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146791","article-title":"Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface","volume":"131","author":"Zost","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2023.112370_bib22","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","article-title":"Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors","volume":"161","author":"Zhou","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112370_bib23","doi-asserted-by":"crossref","first-page":"S528","DOI":"10.1093\/infdis\/jiy333","article-title":"Vaccine generation of protective Ebola antibodies and identification of conserved B-cell signatures","volume":"218","author":"Cagigi","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112370_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12859-020-03649-5","article-title":"PyIR: a scalable wrapper for processing billions of immunoglobulin and T\u00a0cell receptor sequences using IgBLAST","volume":"21","author":"Soto","year":"2020","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.celrep.2023.112370_bib25","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2023.112370_bib26","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/bioinformatics\/btx206","article-title":"RTK: efficient rarefaction analysis of large datasets","volume":"33","author":"Saary","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2023.112370_bib27","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/2041-210X.12613","article-title":"iNEXT: an R package for rarefaction and extrapolation of species diversity (Hill numbers)","volume":"7","author":"Hsieh","year":"2016","journal-title":"Methods Ecol. Evol."},{"key":"10.1016\/j.celrep.2023.112370_bib28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41551-020-0594-x","article-title":"Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics","volume":"4","author":"Gilchuk","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2023.112370_bib29","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","article-title":"Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein","volume":"26","author":"Zost","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112370_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.706757","article-title":"Proteo-genomic analysis identifies two major sites of vulnerability on Ebolavirus glycoprotein for neutralizing antibodies in convalescent human plasma","volume":"12","author":"Gilchuk","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2023.112370_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112370_bib32","article-title":"Sequence signatures of two IGHV3-53\/3-66 public clonotypes to SARS-CoV-2 receptor binding domain","author":"Tan","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2023.112370_bib33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.chom.2018.05.001","article-title":"Multi-Donor longitudinal antibody repertoire sequencing reveals the existence of public antibody clonotypes in HIV-1 infection","volume":"23","author":"Setliff","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112370_bib45","first-page":"S418","article-title":"Ebolavirus chimerization for the development of a mouse model for screening of Bundibugyo-specific antibodies","volume":"218","author":"Ilinykh","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112370_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-019-0879-y","article-title":"Commonality despite exceptional diversity in the baseline human antibody repertoire","volume":"566","author":"Briney","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112370_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-019-0934-8","article-title":"High frequency of shared clonotypes in human B cell receptor repertoires","volume":"566","author":"Soto","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112370_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-induced antibodies that neutralize group 1 and group 2 Influenza A viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112370_bib37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2021.03.004","article-title":"Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses","volume":"54","author":"Mukhamedova","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112370_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92872","article-title":"Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance","volume":"2","author":"Bailey","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2023.112370_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109604","article-title":"Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals","volume":"36","author":"Chen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112370_bib40","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.immuni.2021.08.013","article-title":"A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants","volume":"54","author":"Schmitz","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112370_bib41","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1038\/s41467-021-24123-7","article-title":"Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.112370_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg6916","article-title":"Prolonged evolution of the human B cell response to SARS-CoV-2 infection","volume":"6","author":"Sakharkar","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2023.112370_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coviro.2019.02.004","article-title":"VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design","volume":"34","author":"Chen","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.celrep.2023.112370_bib44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112370_bib50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.immuni.2018.06.018","article-title":"Multifunctional pan-Ebolavirus antibody recognizes a site of broad vulnerability on the Ebolavirus glycoprotein","volume":"49","author":"Gilchuk","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112370_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.AID-0027-2014","article-title":"Use of human hybridoma technology to isolate human monoclonal antibodies","volume":"3","author":"Smith","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.celrep.2023.112370_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112370_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","article-title":"Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening","volume":"332","author":"Towner","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2023.112370_bib60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.virusres.2005.03.028","article-title":"Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda","volume":"113","author":"Sanchez","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.celrep.2023.112370_bib49","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1128\/JVI.00101-16","article-title":"Chimeric filoviruses for identification and characterization of monoclonal antibodies","volume":"90","author":"Ilinykh","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112370_bib48","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112370_bib65","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","article-title":"Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs","volume":"16","author":"Bepler","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2023.112370_bib66","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1038\/s41467-020-18952-1","article-title":"Topaz-Denoise: general deep denoising models for cryoEM and cryoET","volume":"11","author":"Bepler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.112370_bib67","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.celrep.2023.112370_bib63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2023.112370_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.celrep.2023.112370_bib56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0076-6879(96)66026-1","article-title":"Inferring phylogenies from protein sequences by parsimony, distance, and likelihood methods","volume":"266","author":"Felsenstein","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.celrep.2023.112370_bib51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/mp.55.2.98","article-title":"Improvements to B cell clonality analysis using PCR amplification of immunoglobulin light chain genes","volume":"55","author":"Diss","year":"2002","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.celrep.2023.112370_bib52","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"Smith","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2023.112370_bib53","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2023.112370_bib54","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/s41467-019-09278-8","article-title":"Large-scale network analysis reveals the sequence space architecture of antibody repertoires","volume":"10","author":"Miho","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.112370_bib57","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/19420862.2015.1008351","article-title":"Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells","volume":"7","author":"Chng","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2023.112370_bib58","article-title":"Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein","author":"Suryadevara","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2023.112370_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1251\/bpo70","article-title":"Negative staining and image classification - powerful tools in modern electron microscopy","volume":"6","author":"Ohi","year":"2004","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.celrep.2023.112370_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"Mastronarde","year":"2005","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.celrep.2023.112370_bib64","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","article-title":"CTFFIND4: fast and accurate defocus estimation from electron micrographs","volume":"192","author":"Rohou","year":"2015","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.celrep.2023.112370_bib68","article-title":"Serum proteomics expands on high-affinity antibodies in immunized rabbits than deep B-cell repertoire sequencing alone","author":"Bonissone","year":"2021","journal-title":"bioRxiv"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723003819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723003819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:25:43Z","timestamp":1744806343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723003819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2211124723003819"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112370","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"112370"}}